The Current Ratio as of December 2025 (TTM) for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is 3.80

According to Shukra Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 3.80. This represents a change of 100.49% compared to the average of 1.90 of the last 4 quarters.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Historical Current Ratio (quarterly & annually)

How has SHUKRAPHAR.BO Current Ratio performed in the past?

The mean historical Current Ratio of Shukra Pharmaceuticals Limited over the last ten years is 3.27. The current 3.80 Current Ratio has changed 11.54% with respect to the historical average. Over the past ten years (40 quarters), SHUKRAPHAR.BO's Current Ratio was at its highest in in the December 2015 quarter at 15.82. The Current Ratio was at its lowest in in the June 2017 quarter at 0.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Shukra Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Average Current Ratio

How has SHUKRAPHAR.BO Current Ratio performed in the past?

The current Current Ratio of Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Current Ratio vs. Peers

How is SHUKRAPHAR.BO’s Current Ratio compared to its peers?

Shukra Pharmaceuticals Limited’s Current Ratio is greater than Suraksha Diagnostic Limited (1.76), greater than Suraksha Diagnostic Limited (1.76), less than TTK Healthcare Limited (5.68), less than Megasoft Limited (8.39), less than Bliss GVS Pharma Limited (4.46), less than Bliss GVS Pharma Limited (4.46), greater than Tarsons Products Limited (0), greater than Tarsons Products Limited (0), less than Syncom Formulations (India) Limited (4.68), less than Syncom Formulations (India) Limited (4.68),

Build a custom stock screener for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shukra Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shukra Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.